QTTB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Homology Medicines Inc

Watchlist Manager

Watchlist

Price: 15.38 USD 1.99% Market Closed

Market Cap: $260.8m

	Homology Medicines Inc NASDAQ:QTTB	US
	MasTec Inc NYSE:MTZ	US
	Dell Technologies Inc NYSE:DELL	US
C	Cellectis SA XBER:ZVA	FR
A	ACG Acquisition Company Ltd LSE:ACG	VG

Profitability Summary

Homology Medicines Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

31%

Negative 3Y Average Operating Margin

-8.283%

Operating Margin is Increasing

-4.570% > 31%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-8.995%

Net Margin is Increasing

-4.797% > 55%

Negative Free Cash Flow Margin

-62%

Negative 3Y Average Free Cash Flow Margin

-8.338%

Free Cash Flow Margin is Increasing

-3.712% > -62%

Exceptional ROE

125%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-392%

ROIC is Increasing

-267% > 141%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.